Breast cancer is a highly heterogeneous disease and our data cannot unequivocally tell us whether the TIMP‐1/CD74 interaction is of pathophysiological relevance regarding tumor progression or response to treatment. The gene discussed is TIMP1; the disease is breast cancer.